Real-world outcomes with Control-IQ technology including impact on adverse-events

Watch the replay of Dr. Harsimran Singh, Manager of Behavioral Research at Tandem Diabetes Care, and Dr. Robyn Houlden from Division of Endocrinology, Queen’s University, Kingston, Ontario, presenting their webinar: “Real-world outcomes with Control-IQ technology including impact on adverse events.”

Real-world outcomes with Control-IQ technology including impact on adverse-events


* Tandem Diabetes Care will have an exhibit table at each event, but Tandem is not the event organizer and does not have control of the information shared outside of its exhibit space.